finally a distinction between the two with a demand for access to both for front line workers ASAP
http://www.msf.org/article/ebola-msf-urges-immediate-action-vaccines-and-treatments-frontline-workers
“Appropriate incentives that give industry a reason to develop these vital tools for Ebola are needed now – government and donors must line up to help here”, Dr Balasegaram said. “We need researchers and developers to conduct clinical trials in parallel with scaling up production supply, which we know has its inherent risks. Governments and donors must help incentivise this risk, and the path to regulation in getting approved, safe and effective vaccines and treatments on the ground in West Africa needs to be a smooth one.”